AGP Picks
View all

Health Wire Kuwait: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Kuwait.

Press releases published on June 8, 2026

Zealand Pharma - Transactions related to share buy-back program (week 23, 2026)
Xealth Appoints Travis Moore as Chief Revenue Officer
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
EMS Air Ambulance Completes 9,840 km Medical Repatriation from London to San Francisco for Elderly Trauma Patient
Flyte (VTAK) Makes Strategic Investment in Volato (SOAR)
Surgical Simulation Market Expected to Reach USD 349.4 Million by 2030 | MarketsandMarkets™
C-30 et C-31 : Des organisations pancanadiennes demandent à Ottawa de ne pas affaiblir l’encadrement des pesticides
New Task Force to Develop Roadmap for Dementia Care Coordination in Ontario
Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives
Capricor Therapeutics to Present at Upcoming Investor Conferences
Polyrizon Makes Strong Clinical Progress: Secures Three U.S. Sites for NASARIX™ Trial
Healthcare Financial Management Association recognizes Dennis Dahlen for contributions to healthcare
TOMI Environmental Targets Drone-Enabled SteraMist® Technology for High-Growth AI, Autonomous Robotics and Biosecurity Markets
Healthcare Financial Management Association (HFMA) announces Matthew E. Cox as National Chair along with new officers, board members
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
America’s Warrior Partnership Strengthens Data-Driven Approach to Serving Veterans Through Approved Evaluation Framework
National Action Urged to Address Chronic Pain Crisis Among Women and Women Veterans in Canada
Appel À Une Action Nationale Pour Lutter Contre La Crise De La Douleur Chronique Chez Les Femmes Et Les Vétéranes Au Canada
Sharecare to honor extraordinary nurses through The DAISY Foundation’s global recognition program
ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress

Share this page:

Sign up for:

Health Wire Kuwait

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.